Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer
Clinical trial NCT01320501 · SUSPENDED
Trial details
- NCT number
- NCT01320501
- Sponsor
- National Guard Health Affairs
- Status
- SUSPENDED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2016-08-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.